What US Life Sciences growth can teach the UK about talent, investment and scale

The United Kingdom is widely recognised as one of the world’s leading life sciences hubs. From pioneering academic research to breakthrough medicines, diagnostics and medical technologies, the UK consistently produces science that has a global impact.

The UK is home to internationally renowned universities, a highly skilled scientific workforce, and some of the most innovative biotech and pharmaceutical companies in the world. Yet despite these advantages, the UK continues to face a challenge that has persisted for decades: turning world-class science into large-scale, commercially successful life sciences businesses.

According to the Office for Life Sciences, the sector now supports around 360,000 jobs across more than 6,000 businesses and generates almost £147 billion in annual turnover. The industry spans biopharmaceuticals, medical technology, diagnostics, genomics, digital health and advanced therapeutics, making it a significant contributor to both economic growth and healthcare innovation.

The UK has also built internationally recognised innovation clusters, including the Golden Triangle of London, Oxford and Cambridge, alongside growing hubs in the North West, Scotland, Wales and Northern Ireland. These ecosystems bring together academia, healthcare providers, investors and industry in ways that many countries struggle to replicate.

However while the UK excels at discovery and innovation, it often struggles when companies reach the scale-up phase, lagging behind that of faster investment in the United States. For employers, candidates and investors alike, understanding this tension is essential to understanding the future of the sector.

Addressing the talent pipeline gap

One of the most overlooked issues in UK life sciences is the disconnect between scientific education and industry careers.

Approximately 42% of people in the UK hold STEM degrees, compared to just 19% in the US. And yet only around 0.8% of UK workers are employed in the life science sector, versus 1.4% in the US. The US has half the proportion of STEM graduates – but nearly twice the percentage of its workforce in life sciences. Something is clearly going wrong in the pipeline between education and employment.

The UK produces a large number of STEM graduates every year, but many students and early-career professionals still have a narrow understanding of what a career in life sciences can look like. For many, “working in science” remains synonymous with laboratory research.

In reality, modern life sciences organisations rely on a broad range of specialist functions, including:

• Medical Affairs
• Clinical Development
• Regulatory Affairs
• Market Access
• Pharmacovigilance
• Health Economics and Outcomes Research
• Commercial Strategy
• Business Development
• Quality Assurance
• Clinical Operations

Many of these roles require scientific expertise while offering career paths beyond traditional bench science. However, awareness of these opportunities often remains limited, particularly among graduates and early-career professionals.

For employers, this creates an ongoing challenge. Strong candidates exist, but many are not exposed to the full range of opportunities available within the industry.

How to close the clinician-to-industry gap

Another area where the UK continues to lag behind the United States is the movement of clinicians into pharmaceutical and biotech organisations.

In the US, it is relatively common for physicians to transition into industry roles such as Medical Director, Clinical Development Lead, Vice President of Clinical Development or Chief Medical Officer. These pathways are well established and widely understood.

In the UK, that transition is still far less common.

Many doctors are unaware that sponsor-side careers exist or do not fully understand how their clinical expertise translates into drug development, medical affairs or strategic leadership roles. As a result, organisations frequently face challenges recruiting experienced physicians into industry positions.

With demand for medical expertise increasing across biotech, pharmaceutical and medtech companies, improving awareness of these career pathways could unlock a valuable source of talent for the sector.

Improving on the ability to scale and produce investment in development

The UK has developed an impressive track record of creating innovative life sciences companies. Early-stage funding, university spinouts and scientific entrepreneurship have all improved significantly over the past two decades. However, many businesses encounter difficulties when they need larger rounds of growth capital to fund late-stage clinical development, international expansion or commercial launch activities.

Compared with the United States, the UK has fewer large specialist investors with the scale and risk appetite required to support long development timelines. As a result, many promising UK companies eventually seek funding from overseas investors.

While this provides access to essential capital, it can also lead to intellectual property, leadership teams and future growth becoming increasingly concentrated outside the UK. This pattern has become familiar across the sector: UK science, international funding, and often international ownership.

It is not necessarily a failure of individual companies. Rather, it reflects differences in the maturity and depth of the investment ecosystems available to them.

Reasons for optimism

Despite these challenges, there are encouraging signs.

The UK Government continues to identify life sciences as a strategic growth sector and has outlined ambitions to make the UK one of the world’s leading life sciences economies. Recent sector plans have highlighted opportunities for the industry to contribute billions of pounds in additional economic value over the coming decade.

The UK also remains highly competitive in areas such as:

• Academic research excellence
• Genomics and precision medicine
• Cell and gene therapy
• Artificial intelligence in healthcare
• Clinical research infrastructure
• University spinout creation

The continued growth of established clusters around Cambridge, Oxford, London, Manchester, Edinburgh and other regional centres is helping attract both domestic and international investment.

If the UK wants to fully realise its life sciences potential, several priorities stand out:

• Greater visibility of non-laboratory careers for STEM graduates
• More structured pathways for clinicians entering industry
• Stronger connections between academia and commercial organisations
• Increased availability of scale-up capital
• Continued investment in regional life sciences clusters
• Faster translation of scientific discovery into commercial opportunity

The UK continues to produce some of the best science in the world. The challenge is building the infrastructure, talent pathways and investment environment needed to transform that science into globally scaled businesses.

For hiring managers, this creates both challenges and opportunities. Competition for specialist talent remains high, but organisations that can clearly communicate career progression, purpose and long-term growth potential are increasingly well positioned to attract the people who will shape the next generation of life sciences innovation.

Looking for expert support in hiring within Life Sciences, biotech and pharma? 

We support organisations across the full product lifecycle through dedicated specialist teams operating exclusively within niche functional markets. This focus enables us to deliver deeper market knowledge, stronger talent networks, and access to high-calibre candidates that generalist recruiters often cannot reach.

We pride ourselves on building long-term partnerships with clients, acting as trusted advisors rather than transactional suppliers. Our commitment to exceptional service is reflected in our 4.9 Google rating and longstanding relationships across the industry.

Notably, much of our work is now conducted through exclusive partnerships, enabling us to provide a highly tailored, high-quality service that drives long-term talent retention and business success. 

Looking for your next role? 

Hayley Shayestehroo

Senior Consultant